Clene Inc.
CLNN • NASDAQ
Clene Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Etherington, with a market cap of $74.7M.
Market Cap$74.7M
Employees85.0
CEORobert Etherington
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Clene Inc. FAQ
Common questions about Clene Inc.
Clene Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $36.3K.
Clene Inc. has approximately 85 employees.